Inhibition of autolysosomes by repurposing drugs as a promising therapeutic strategy for the treatment of cancers

References

• Aits S, Jaattela M. 2013. Lysosomal cell death at a glance. J Cell Sci. 126:1905–1912.
   PubMed Web of Science ®Google Scholar
• Al-Bari MA. 2015. Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother. 70:1608–1621.
   PubMed Web of Science ®Google Scholar
• Al-Bari MAA. 2020. A current view of molecular dissection in autophagy machinery. J Physiol Biochem. 76:357–372.
   PubMed Web of Science ®Google Scholar
• Al-Bari MAA, Xu P. 2020. Molecular regulation of autophagy machinery by mTOR-dependent and -independent pathways. Ann N Y Acad Sci. 1467:3–20.
   PubMed Web of Science ®Google Scholar
• Aman Y, Schmauck-Medina T, Hansen M, Morimoto RI, Simon AK, Bjedov I, Palikaras K, Simonsen A, Johansen T, Tavernarakis N, et al. 2021. Autophagy in healthy aging and disease. Nat Aging. 1:634–650.
   PubMedGoogle Scholar
• Amaravadi R, Kimmelman AC, White E. 2016. Recent insights into the function of autophagy in cancer. Genes Dev. 30:1913–1930.
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Winkler JD. 2012. Lys05: a new lysosomal autophagy inhibitor. Autophagy. 8:1383–1384.
   PubMed Web of Science ®Google Scholar
• Angelidou I, Chrysanthopoulou A, Mitsios A, Arelaki S, Arampatzioglou A, Kambas K, Ritis D, Tsironidou V, Moschos I, Dalla V, et al. 2018. REDD1/autophagy pathway is associated with neutrophil-driven IL-1beta inflammatory response in active ulcerative colitis. J Immunol. 200:3950–3961.
   PubMed Web of Science ®Google Scholar
• Avalos Y, Canales J, Bravo-Sagua R, Criollo A, Lavandero S, Quest AF. 2014. Tumor suppression and promotion by autophagy. Biomed Res Int. 2014:1–15.
   Web of Science ®Google Scholar
• Avivar-Valderas A, Bobrovnikova-Marjon E, Alan Diehl J, Bardeesy N, Debnath J, Aguirre-Ghiso JA. 2013. Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. Oncogene. 32:4932–4940.
   PubMed Web of Science ®Google Scholar
• Bahrami A, Bianconi V, Pirro M, Orafai HM, Sahebkar A. 2020. The role of TFEB in tumor cell autophagy: diagnostic and therapeutic opportunities. Life Sci. 244:117341.
   PubMed Web of Science ®Google Scholar
• Baker NC, Ekins S, Williams AJ, Tropsha A. 2018. A bibliometric review of drug repurposing. Drug Discov Today. 23:661–672.
   PubMed Web of Science ®Google Scholar
• Ballabio A. 2016. The awesome lysosome. EMBO Mol Med. 8:73–76.
   PubMed Web of Science ®Google Scholar
• Ballabio A, Bonifacino JS. 2020. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat Rev Mol Cell Biol. 21:101–118.
   PubMed Web of Science ®Google Scholar
• Barazzuol L, Giamogante F, Brini M, Cali T. 2020. PINK1/parkin mediated mitophagy, Ca(2+) signalling, and ER-mitochondria contacts in Parkinson's disease. Int J Mol Sci. 21:1772.
   PubMed Web of Science ®Google Scholar
• Bartsch K, Knittler K, Borowski C, Rudnik S, Damme M, Aden K, Spehlmann ME, Frey N, Saftig P, Chalaris A, Rabe B. 2017. Absence of RNase H2 triggers generation of immunogenic micronuclei removed by autophagy. Hum Mol Genet. 26:3960–3972.
   PubMed Web of Science ®Google Scholar
• Behrends C, Sowa ME, Gygi SP, Harper JW. 2010. Network organization of the human autophagy system. Nature. 466:68–76.
   PubMed Web of Science ®Google Scholar
• Brown GT, Murray GI. 2015. Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 237:273–281.
   PubMed Web of Science ®Google Scholar
• Burman C, Ktistakis NT. 2010. Autophagosome formation in mammalian cells. Semin Immunopathol. 32:397–413.
   PubMed Web of Science ®Google Scholar
• Byrne S, Jansen L, U-King-Im JM, Siddiqui A, Lidov HG, Bodi I, Smith L, Mein R, Cullup T, Dionisi-Vici C, et al. 2016. EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy. Brain. 139:765–781.
   PubMed Web of Science ®Google Scholar
• Cai M, Hu Z, Liu J, Gao J, Liu C, Liu D, Tan M, Zhang D, Lin B. 2014. Beclin 1 expression in ovarian tissues and its effects on ovarian cancer prognosis. Int J Mol Sci. 15:5292–5303.
   PubMed Web of Science ®Google Scholar
• Cai Q, Yan L, Xu Y. 2015. Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells. Oncogene. 34:3315–3324.
   PubMed Web of Science ®Google Scholar
• Cao B, Li J, Zhou X, Juan J, Han K, Zhang Z, Kong Y, Wang J, Mao X. 2014. Clioquinol induces pro-death autophagy in leukemia and myeloma cells by disrupting the mTOR signaling pathway. Sci Rep. 4:5749.
   PubMed Web of Science ®Google Scholar
• Ceccariglia S, Cargnoni A, Silini AR, Parolini O. 2020. Autophagy: a potential key contributor to the therapeutic action of mesenchymal stem cells. Autophagy. 16:28–37.
   PubMed Web of Science ®Google Scholar
• Chang NC. 2020. Autophagy and stem cells: self-eating for self-renewal. Front Cell Dev Biol. 8:138.
   PubMed Web of Science ®Google Scholar
• Chang X, Dong R. 2020. Transcriptional regulation of autophagy-lysosomal pathway in cancer. Thorac Cancer. 11:216–223.
   PubMed Web of Science ®Google Scholar
• Chauhan S, Kumar S, Jain A, Ponpuak M, Mudd MH, Kimura T, Choi SW, Peters R, Mandell M, Bruun JA, et al. 2016. TRIMs and galectins globally cooperate and TRIM16 and galectin-3 co-direct autophagy in endomembrane damage homeostasis. Dev Cell. 39:13–27.
   PubMed Web of Science ®Google Scholar
• Chen R, Jaattela M, Liu B. 2020. Lysosome as a central hub for rewiring PH homeostasis in tumors. Cancers (Basel). 12(9):2437.
   Web of Science ®Google Scholar
• Chen Y, Yu L. 2018. Development of research into autophagic lysosome reformation. Mol Cells. 41:45–49.
   PubMed Web of Science ®Google Scholar
• Chen Z, Jiang Q, Zhu P, Chen Y, Xie X, Du Z, Jiang L, Tang W. 2019. NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer. Prostate. 79:44–53.
   PubMed Web of Science ®Google Scholar
• Cheung KS, Leung WK. 2019. Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence. Therap Adv Gastroenterol. 12:1756284819834511.
   Web of Science ®Google Scholar
• Christ L, Raiborg C, Wenzel EM, Campsteijn C, Stenmark H. 2017. Cellular functions and molecular mechanisms of the ESCRT membrane-scission machinery. Trends Biochem Sci. 42:42–56.
   PubMed Web of Science ®Google Scholar
• Chude CI, Amaravadi RK. 2017. Targeting autophagy in cancer: update on clinical trials and novel inhibitors. Int J Mol Sci. 18:1279.
   PubMed Web of Science ®Google Scholar
• Coss RA, Storck CW, Daskalakis C, Berd D, Wahl ML. 2003. Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells. Mol Cancer Ther. 2:383–388.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Zitvogel L, Palucka AK. 2013. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science. 339:286–291.
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Wong E. 2014. Chaperone-mediated autophagy: roles in disease and aging. Cell Res. 24:92–104.
   PubMed Web of Science ®Google Scholar
• Daskalaki I, Gkikas I, Tavernarakis N. 2018. Hypoxia and selective autophagy in cancer development and therapy. Front Cell Dev Biol. 6:104.
   PubMed Web of Science ®Google Scholar
• Davidson SM, Vander Heiden MG. 2017. Critical functions of the lysosome in cancer biology. Annu Rev Pharmacol Toxicol. 57:481–507.
   PubMed Web of Science ®Google Scholar
• De Mei C, Ercolani L, Parodi C, Veronesi M, Lo Vecchio C, Bottegoni G, Torrente E, Scarpelli R, Marotta R, Ruffili R, et al. 2015. Dual inhibition of REV-ERBbeta and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells. Oncogene. 34:2597–2608.
   PubMed Web of Science ®Google Scholar
• De Milito A, Canese R, Marino ML, Borghi M, Iero M, Villa A, Venturi G, Lozupone F, Iessi E, Logozzi M, et al. 2010. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer. 127:207–219.
   PubMed Web of Science ®Google Scholar
• De Milito A, Iessi E, Logozzi M, Lozupone F, Spada M, Marino ML, Federici C, Perdicchio M, Matarrese P, Lugini L, et al. 2007. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Res. 67:5408–5417.
   PubMed Web of Science ®Google Scholar
• de Souza Pereira C, Costa Quadros H, Magalhaes Moreira DR, Castro W, De Deus Da Silva RIS, Pereira Soares MB, Fontinha D, Prudencio M, Schmitz V, Dos Santos HF, et al. 2021. A novel hybrid of chloroquine and primaquine linked by gold(I): multitarget and multiphase antiplasmodial agent. ChemMedChem. 16:662–678.
   PubMed Web of Science ®Google Scholar
• Devis-Jauregui L, Eritja N, Davis ML, Matias-Guiu X, Llobet-Navas D. 2021. Autophagy in the physiological endometrium and cancer. Autophagy. 17(5): 1077–1095.
   Google Scholar
• DiMasi JA, Grabowski HG, Hansen RW. 2016. Innovation in the pharmaceutical industry: New estimates of R&D costs. J Health Econ. 47:20–33.
   PubMed Web of Science ®Google Scholar
• Dong C, Zheng H, Huang S, You N, Xu J, Ye X, Zhu Q, Feng Y, You Q, Miao H, et al. 2015. Heme oxygenase-1 enhances autophagy in podocytes as a protective mechanism against high glucose-induced apoptosis. Exp Cell Res. 337:146–159.
   PubMed Web of Science ®Google Scholar
• Donohue E, Tovey A, Vogl AW, Arns S, Sternberg E, Young RN, Roberge M. 2011. Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin. J Biol Chem. 286:7290–7300.
   PubMed Web of Science ®Google Scholar
• Dossou AS, Basu A. 2019. The emerging roles of mTORC1 in macromanaging autophagy. Cancers (Basel). 11:1422.
   PubMed Web of Science ®Google Scholar
• Dou Z, Xu C, Donahue G, Shimi T, Pan JA, Zhu J, Ivanov A, Capell BC, Drake AM, Shah PP, et al. 2015. Autophagy mediates degradation of nuclear lamina. Nature. 527:105–109.
   PubMed Web of Science ®Google Scholar
• Drake MT, Clarke BL, Oursler MJ, Khosla S. 2017. Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned. Endocr Rev. 38:325–350.
   PubMed Web of Science ®Google Scholar
• Emanuele E. 2014. Can trehalose prevent neurodegeneration? insights from experimental studies. Curr Drug Targets. 15:551–557.
   PubMed Web of Science ®Google Scholar
• Eng CH, Wang Z, Tkach D, Toral-Barza L, Ugwonali S, Liu S, Fitzgerald SL, George E, Frias E, Cochran N, et al. 2016. Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy. Proc Natl Acad Sci USA. 113:182–187.
   PubMed Web of Science ®Google Scholar
• Fais S, De Milito A, You H, Qin W. 2007. Targeting vacuolar H+-ATPases as a new strategy against cancer. Cancer Res. 67:10627–10630.
   PubMed Web of Science ®Google Scholar
• Franke A, Balschun T, Sina C, Ellinghaus D, Hasler R, Mayr G, Albrecht M, Wittig M, Buchert E, Nikolaus S, et al. 2010. Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet. 42:292–294.
   PubMed Web of Science ®Google Scholar
• Franklin RA, Liao W, Sarkar A, Kim MV, Bivona MR, Liu K, Pamer EG, Li MO. 2014. The cellular and molecular origin of tumor-associated macrophages. Science. 344:921–925.
   PubMed Web of Science ®Google Scholar
• Fridman WH, Zitvogel L, Sautes-Fridman C, Kroemer G. 2017. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 14:717–734.
   PubMed Web of Science ®Google Scholar
• Fuchs N, Meta M, Schuppan D, Nuhn L, Schirmeister T. 2020. Novel opportunities for cathepsin S inhibitors in cancer immunotherapy by nanocarrier-mediated delivery. Cells. 9:2021.
   Web of Science ®Google Scholar
• Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI, et al. 2017. Molecular definitions of autophagy and related processes. EMBO J. 36:1811–1836.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Bravo-San Pedro JM, Demaria S, Formenti SC, Kroemer G. 2017. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nat Rev Clin Oncol. 14:247–258.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G. 2017. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat Rev Drug Discov. 16:487–511.
   PubMed Web of Science ®Google Scholar
• Ganley IG, Wong PM, Gammoh N, Jiang X. 2011. Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell. 42:731–743.
   PubMed Web of Science ®Google Scholar
• Garcia-Prat L, Martinez-Vicente M, Perdiguero E, Ortet L, Rodriguez-Ubreva J, Rebollo E, Ruiz-Bonilla V, Gutarra S, Ballestar E, Serrano AL, et al. 2016. Autophagy maintains stemness by preventing senescence. Nature. 529:37–42.
   PubMed Web of Science ®Google Scholar
• Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, Peters C, Hanahan D, Joyce JA. 2006. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20:543–556.
   PubMed Web of Science ®Google Scholar
• Goel S, Huang J, Klampfer L. 2015. K-Ras, intestinal homeostasis and colon cancer. Curr Clin Pharmacol. 10:73–81.
   PubMed Web of Science ®Google Scholar
• Goodall ML, Wang T, Martin KR, Kortus MG, Kauffman AL, Trent JM, Gately S, MacKeigan JP. 2014. Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib. Autophagy. 10:1120–1136.
   PubMed Web of Science ®Google Scholar
• Granato M, Lacconi V, Peddis M, Lotti LV, Di Renzo L, Gonnella R, Santarelli R, Trivedi P, Frati L, D'Orazi G, et al. 2013. HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma. Cell Death Dis. 4:e730.
   PubMed Web of Science ®Google Scholar
• Groman JD, Meyer ME, Wilmott RW, Zeitlin PL, Cutting GR. 2002. Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med. 347:401–407.
   PubMedGoogle Scholar
• Groth-Pedersen L, Jaattela M. 2013. Combating apoptosis and multidrug resistant cancers by targeting lysosomes. Cancer Lett. 332:265–274.
   PubMed Web of Science ®Google Scholar
• Guo H, Chitiprolu M, Gagnon D, Meng L, Perez-Iratxeta C, Lagace D, Gibbings D. 2014. Autophagy supports genomic stability by degrading retrotransposon RNA. Nat Commun. 5:5276.
   PubMed Web of Science ®Google Scholar
• Hamacher-Brady A, Brady NR, Gottlieb RA. 2006. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem. 281:29776–29787.
   PubMed Web of Science ®Google Scholar
• He L, Zhang J, Zhao J, Ma N, Kim SW, Qiao S, Ma X. 2018. Autophagy: The last defense against cellular nutritional stress. Adv Nutr. 9:493–504.
   PubMed Web of Science ®Google Scholar
• He S, Zhao Z, Yang Y, O'Connell D, Zhang X, Oh S, Ma B, Lee JH, Zhang T, Varghese B, et al. 2015. Truncating mutation in the autophagy gene UVRAG confers oncogenic properties and chemosensitivity in colorectal cancers. Nat Commun. 6:7839.
   PubMed Web of Science ®Google Scholar
• Holzen L, Parigiani MA, Reinheckel T. 2020. Tumor cell- and microenvironment-specific roles of cysteine cathepsins in mouse models of human cancers. Biochim Biophys Acta Proteins Proteom. 1868:140423.
   PubMed Web of Science ®Google Scholar
• Howe MK, Bodoor K, Carlson DA, Hughes PF, Alwarawrah Y, Loiselle DR, Jaeger AM, Darr DB, Jordan JL, Hunter LM, et al. 2014. Identification of an allosteric small-molecule inhibitor selective for the inducible form of heat shock protein 70. Chem Biol. 21:1648–1659.
   PubMedGoogle Scholar
• Huber V, Camisaschi C, Berzi A, Ferro S, Lugini L, Triulzi T, Tuccitto A, Tagliabue E, Castelli C, Rivoltini L. 2017. Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation. Semin Cancer Biol. 43:74–89.
   PubMed Web of Science ®Google Scholar
• Hurley JH, Young LN. 2017. Mechanisms of autophagy initiation. Annu Rev Biochem. 86:225–244.
   PubMed Web of Science ®Google Scholar
• Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, Ishihara N, Mizushima N, Tanida I, Kominami E, Ohsumi M, et al. 2000. A ubiquitin-like system mediates protein lipidation. Nature. 408:488–492.
   PubMed Web of Science ®Google Scholar
• Jang JH, Baerts L, Waumans Y, De Meester I, Yamada Y, Limani P, Gil-Bazo I, Weder W, Jungraithmayr W. 2015. Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice. Clin Exp Metastasis. 32:677–687.
   PubMed Web of Science ®Google Scholar
• Jang JH, Janker F, De Meester I, Arni S, Borgeaud N, Yamada Y, Gil Bazo I, Weder W, Jungraithmayr W. 2019. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity. Carcinogenesis. 40:324–334.
   PubMed Web of Science ®Google Scholar
• Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rossor MN, Collinge J. 2003. Early onset familial Alzheimer's disease: mutation frequency in 31 families. Neurology. 60:235–239.
   PubMed Web of Science ®Google Scholar
• Jewell JL, Russell RC, Guan KL. 2013. Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol. 14:133–139.
   PubMed Web of Science ®Google Scholar
• Jia J, Abudu YP, Claude-Taupin A, Gu Y, Kumar S, Choi SW, Peters R, Mudd MH, Allers L, Salemi M, et al. 2018. Galectins control mTOR in response to Endomembrane damage. Mol Cell. 70:120–135. e128.
   PubMed Web of Science ®Google Scholar
• Jutten B, Keulers TG, Schaaf MB, Savelkouls K, Theys J, Span PN, Vooijs MA, Bussink J, Rouschop KM. 2013. EGFR overexpressing cells and tumors are dependent on autophagy for growth and survival. Radiother Oncol. 108:479–483.
   PubMed Web of Science ®Google Scholar
• Kallifatidis G, Hoepfner D, Jaeg T, Guzman EA, Wright AE. 2013. The marine natural product manzamine A targets vacuolar ATPases and inhibits autophagy in pancreatic cancer cells. Mar Drugs. 11:3500–3516.
   PubMed Web of Science ®Google Scholar
• Kallunki T, Olsen OD, Jaattela M. 2013. Cancer-associated lysosomal changes: friends or foes? Oncogene. 32:1995–2004.
   PubMed Web of Science ®Google Scholar
• Karan D, Dubey S, Pirisi L, Nagel A, Pina I, Choo YM, Hamann MT. 2020. The marine natural product manzamine A inhibits cervical cancer by targeting the SIX1 protein. J Nat Prod. 83:286–295.
   PubMed Web of Science ®Google Scholar
• Karnoub AE, Weinberg RA. 2008. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol. 9:517–531.
   PubMed Web of Science ®Google Scholar
• Karsli-Uzunbas G, Guo JY, Price S, Teng X, Laddha SV, Khor S, Kalaany NY, Jacks T, Chan CS, Rabinowitz JD, White E. 2014. Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov. 4:914–927.
   PubMed Web of Science ®Google Scholar
• Kenific CM, Thorburn A, Debnath J. 2010. Autophagy and metastasis: another double-edged sword. Curr Opin Cell Biol. 22:241–245.
   PubMed Web of Science ®Google Scholar
• Khambu B, Yan S, Huda N, Liu G, Yin XM. 2018. Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease. Liver Res. 2:112–119.
   PubMedGoogle Scholar
• Khan R, Khan H, Abdullah Y, Dou QP. 2020. Feasibility of repurposing clioquinol for cancer therapy. Recent Pat Anticancer Drug Discov. 15:14–31.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, Guan KL. 2011. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 13:132–141.
   PubMed Web of Science ®Google Scholar
• Kim MS, Jeong EG, Ahn CH, Kim SS, Lee SH, Yoo NJ. 2008. Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability. Hum Pathol. 39:1059–1063.
   PubMed Web of Science ®Google Scholar
• Kirkegaard T, Jaattela M. 2009. Lysosomal involvement in cell death and cancer. Biochim Biophys Acta. 1793:746–754.
   PubMed Web of Science ®Google Scholar
• Knott SRV, Wagenblast E, Khan S, Kim SY, Soto M, Wagner M, Turgeon MO, Fish L, Erard N, Gable AL, et al. 2018. Asparagine bioavailability governs metastasis in a model of breast cancer. Nature. 554:378–381.
   PubMed Web of Science ®Google Scholar
• Kondratskyi A, Yassine M, Slomianny C, Kondratska K, Gordienko D, Dewailly E, Lehen'kyi V, Skryma R, Prevarskaya N. 2014. Identification of ML-9 as a lysosomotropic agent targeting autophagy and cell death. Cell Death Dis. 5:e1193.
   PubMed Web of Science ®Google Scholar
• Kos J, Mitrovic A, Mirkovic B. 2014. The current stage of cathepsin B inhibitors as potential anticancer agents. Future Med Chem. 6:1355–1371.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L. 2017. Lysosome-targeting agents in cancer therapy. Oncotarget. 8:112168–112169.
   PubMedGoogle Scholar
• Kroemer G, Senovilla L, Galluzzi L, Andre F, Zitvogel L. 2015. Natural and therapy-induced immunosurveillance in breast cancer. Nat Med. 21:1128–1138.
   PubMed Web of Science ®Google Scholar
• Kubisch R, Frohlich T, Arnold GJ, Schreiner L, von Schwarzenberg K, Roidl A, Vollmar AM, Wagner E. 2014. V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivo. Int J Cancer. 134:2478–2488.
   PubMed Web of Science ®Google Scholar
• Kumar S, Stokes J 3rd, Singh UP, Scissum Gunn K, Acharya A, Manne U, Mishra M. 2016. Targeting hsp70: A possible therapy for cancer. Cancer Lett. 374:156–166.
   PubMed Web of Science ®Google Scholar
• Kwakye-Berko F, Meshnick SR. 1989. Binding of chloroquine to DNA. Mol Biochem Parasitol. 35:51–55.
   PubMed Web of Science ®Google Scholar
• Lamb CA, Yoshimori T, Tooze SA. 2013. The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol. 14:759–774.
   PubMed Web of Science ®Google Scholar
• Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, Stevens DM, Davis JG, Salmon AB, Richardson A, Ahima RS, et al. 2012. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 335:1638–1643.
   PubMed Web of Science ®Google Scholar
• Langedijk J, Mantel-Teeuwisse AK, Slijkerman DS, Schutjens MH. 2015. Drug repositioning and repurposing: terminology and definitions in literature. Drug Discov Today. 20:1027–1034.
   PubMed Web of Science ®Google Scholar
• Lee JK, Shin JH, Lee JE, Choi EJ. 2015. Role of autophagy in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta. 1852:2517–2524.
   PubMed Web of Science ®Google Scholar
• Le Scolan E, Pchejetski D, Banno Y, Denis N, Mayeux P, Vainchenker W, Levade T, Moreau-Gachelin F. 2005. Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression. Blood. 106:1808–1816.
   PubMed Web of Science ®Google Scholar
• Leturiondo AL, Noronha AB, Mendonca CYR, Ferreira CO, Alvarado-Arnez LE, Manta FSN, Bezerra OCL, Carvalho EF, Moraes MO, Rodrigues FDC, Talhari C. 2020. Association of NOD2 and IFNG single nucleotide polymorphisms with leprosy in the Amazon ethnic admixed population. PLoS Negl Trop Dis. 14:e0008247.
   PubMed Web of Science ®Google Scholar
• Levy JM, Thompson JC, Griesinger AM, Amani V, Donson AM, Birks DK, Morgan MJ, Mirsky DM, Handler MH, Foreman NK, Thorburn A. 2014. Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors. Cancer Discov. 4:773–780.
   PubMed Web of Science ®Google Scholar
• Levy JMM, Towers CG, Thorburn A. 2017. Targeting autophagy in cancer. Nat Rev Cancer. 17:528–542.
   PubMed Web of Science ®Google Scholar
• Li DL, Wang ZV, Ding G, Tan W, Luo X, Criollo A, Xie M, Jiang N, May H, Kyrychenko V, et al. 2016. Doxorubicin blocks cardiomyocyte autophagic flux by inhibiting lysosome acidification. Circulation. 133:1668–1687.
   PubMed Web of Science ®Google Scholar
• Li J, Yang B, Zhou Q, Wu Y, Shang D, Guo Y, Song Z, Zheng Q, Xiong J. 2013. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition. Carcinogenesis. 34:1343–1351.
   PubMed Web of Science ®Google Scholar
• Li LQ, Xie WJ, Pan D, Chen H, Zhang L. 2016. Inhibition of autophagy by bafilomycin A1 promotes chemosensitivity of gastric cancer cells. Tumour Biol. 37:653–659.
   PubMedGoogle Scholar
• Li P, Shi M, Maique J, Shaffer J, Yan S, Moe OW, Hu MC. 2020. Beclin 1/Bcl-2 complex-dependent autophagy activity modulates renal susceptibility to ischemia-reperfusion injury and mediates renoprotection by Klotho. Am J Physiol Renal Physiol. 318:F772–F792.
   PubMed Web of Science ®Google Scholar
• Li W, He P, Huang Y, Li YF, Lu J, Li M, Kurihara H, Luo Z, Meng T, Onishi M, et al. 2021. Selective autophagy of intracellular organelles: recent research advances. Theranostics. 11:222–256.
   PubMed Web of Science ®Google Scholar
• Li YY, Feun LG, Thongkum A, Tu CH, Chen SM, Wangpaichitr M, Wu C, Kuo MT, Savaraj N. 2017. Autophagic mechanism in anti-cancer immunity: Its Pros and cons for cancer therapy. Int J Mol Sci. 18(6):1297.
   Web of Science ®Google Scholar
• Liang J, Wang L, Wang C, Shen J, Su B, Marisetty AL, Fang D, Kassab C, Jeong KJ, Zhao W, et al. 2020. Verteporfin inhibits PD-L1 through autophagy and the STAT1-IRF1-TRIM28 signaling axis, exerting antitumor efficacy. Cancer Immunol Res. 8:952–965.
   PubMed Web of Science ®Google Scholar
• Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. 1999. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 402:672–676.
   PubMed Web of Science ®Google Scholar
• Lieberman AP, Puertollano R, Raben N, Slaugenhaupt S, Walkley SU, Ballabio A. 2012. Autophagy in lysosomal storage disorders. Autophagy. 8:719–730.
   PubMed Web of Science ®Google Scholar
• Liu B, Palmfeldt J, Lin L, Colaco A, Clemmensen KKB, Huang J, Xu F, Liu X, Maeda K, Luo Y, Jaattela M. 2018. STAT3 associates with vacuolar H(+)-ATPase and regulates cytosolic and lysosomal pH. Cell Res. 28:996–1012.
   PubMed Web of Science ®Google Scholar
• Liu J, Xia H, Kim M, Xu L, Li Y, Zhang L, Cai Y, Norberg HV, Zhang T, Furuya T, et al. 2011. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell. 147:223–234.
   PubMed Web of Science ®Google Scholar
• Liu K, Lee J, Kim JY, Wang L, Tian Y, Chan ST, Cho C, Machida K, Chen D, Ou JJ. 2017. Mitophagy controls the activities of tumor suppressor p53 to regulate hepatic cancer stem cells. Mol Cell. 68:281–292.e285.
   PubMed Web of Science ®Google Scholar
• Liu S, Wang L, Ding W, Wang D, Wang X, Luo Q, Lu Y, Zhu L. 2020. Cleistanthin A inhibits the invasion of MDA-MB-231 human breast cancer cells: involvement of the beta-catenin pathway. Pharmacol Rep. 72:188–198.
   PubMed Web of Science ®Google Scholar
• Liu W, Qi Y, Liu L, Tang Y, Wei J, Zhou L. 2016. Suppression of tumor cell proliferation by quinine via the inhibition of the tumor necrosis factor receptorassociated factor 6AKT interaction. Mol Med Rep. 14:2171–2179.
   PubMed Web of Science ®Google Scholar
• Lopez E, Casasnovas C, Gimenez J, Santamaria R, Terrazas JM, Volpini V. 2015. Identification of two novel KIF5A mutations in hereditary spastic paraplegia associated with mild peripheral neuropathy. J Neurol Sci. 358:422–427.
   PubMed Web of Science ®Google Scholar
• Lopez-Hernandez T, Puchkov D, Krause E, Maritzen T, Haucke V. 2020. Endocytic regulation of cellular ion homeostasis controls lysosome biogenesis. Nat Cell Biol. 22:815–827.
   PubMed Web of Science ®Google Scholar
• Lu F, Hu Z, Sinard J, Garen A, Adelman RA. 2009. Factor VII-verteporfin for targeted photodynamic therapy in a rat model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 50:3890–3896.
   PubMed Web of Science ®Google Scholar
• Luciani A, Villella VR, Esposito S, Brunetti-Pierri N, Medina DL, Settembre C, Gavina M, Raia V, Ballabio A, Maiuri L. 2011. Cystic fibrosis: a disorder with defective autophagy. Autophagy. 7:104–106.
   PubMed Web of Science ®Google Scholar
• Luciani F, Spada M, De Milito A, Molinari A, Rivoltini L, Montinaro A, Marra M, Lugini L, Logozzi M, Lozupone F, et al. 2004. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst. 96:1702–1713.
   PubMed Web of Science ®Google Scholar
• Ma C, Storer CE, Chandran U, LaFramboise WA, Petrosko P, Frank M, Hartman DJ, Pantanowitz L, Haritunians T, Head RD, Liu TC. 2021. Crohn's disease-associated ATG16L1 T300A genotype is associated with improved survival in gastric cancer. EBioMedicine. 67:103347.
   PubMed Web of Science ®Google Scholar
• Mae Y, Kanda T, Sugihara T, Takata T, Kinoshita H, Sakaguchi T, Hasegawa T, Tarumoto R, Edano M, Kurumi H, et al. 2020. Verteporfin-photodynamic therapy is effective on gastric cancer cells. Mol Clin Oncol. 13:10.
   PubMed Web of Science ®Google Scholar
• Maejima I, Takahashi A, Omori H, Kimura T, Takabatake Y, Saitoh T, Yamamoto A, Hamasaki M, Noda T, Isaka Y, Yoshimori T. 2013. Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. EMBO J. 32:2336–2347.
   PubMed Web of Science ®Google Scholar
• Maes H, Kuchnio A, Peric A, Moens S, Nys K, De Bock K, Quaegebeur A, Schoors S, Georgiadou M, Wouters J, et al. 2014. Tumor vessel normalization by chloroquine independent of autophagy. Cancer Cell. 26:190–206.
   PubMed Web of Science ®Google Scholar
• Mahapatra KK, Mishra SR, Behera BP, Patil S, Gewirtz DA, Bhutia SK. 2021. The lysosome as an imperative regulator of autophagy and cell death. Cell Mol Life Sci. 78:7435–7449.
   PubMed Web of Science ®Google Scholar
• Mainz L, Rosenfeldt MT. 2018. Autophagy and cancer - insights from mouse models. FEBS J. 285:792–808.
   PubMed Web of Science ®Google Scholar
• Maiuri L, Raia V, Piacentini M, Tosco A, Villella VR, Kroemer G. 2019. Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease. Oncotarget. 10:4492–4500.
   PubMedGoogle Scholar
• Majer F, Vlaskova H, Krol L, Kalina T, Kubanek M, Stolnaya L, Dvorakova L, Elleder M, Sikora J. 2012. Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency. Gene. 498:183–195.
   PubMed Web of Science ®Google Scholar
• Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, et al. 2007. Foxo3 controls autophagy in skeletal muscle in vivo. Cell Metab. 6:458–471.
   PubMed Web of Science ®Google Scholar
• Marciniak SJ, Lomas DA. 2010. Alpha1-antitrypsin deficiency and autophagy. N Engl J Med. 363:1863–1864.
   PubMed Web of Science ®Google Scholar
• Margeta M. 2020. Autophagy defects in skeletal myopathies. Annu Rev Pathol. 15:261–285.
   PubMed Web of Science ®Google Scholar
• Martin DD, Ladha S, Ehrnhoefer DE, Hayden MR. 2015. Autophagy in huntington disease and huntingtin in autophagy. Trends Neurosci. 38:26–35.
   PubMed Web of Science ®Google Scholar
• Martin LJ, Gupta J, Jyothula SS, Butsch Kovacic M, Biagini Myers JM, Patterson TL, Ericksen MB, He H, Gibson AM, Baye TM, et al. 2012. Functional variant in the autophagy-related 5 gene promotor is associated with childhood asthma. PLoS One. 7:e33454.
   PubMed Web of Science ®Google Scholar
• Martina JA, Chen Y, Gucek M, Puertollano R. 2012. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy. 8:903–914.
   PubMed Web of Science ®Google Scholar
• Mathew R, Karantza-Wadsworth V, White E. 2007. Role of autophagy in cancer. Nat Rev Cancer. 7:961–967.
   PubMed Web of Science ®Google Scholar
• Maxson ME, Grinstein S. 2014. The vacuolar-type H(+)-ATPase at a glance – more than a proton pump. J Cell Sci. 127:4987–4993.
   PubMed Web of Science ®Google Scholar
• Maycotte P, Aryal S, Cummings CT, Thorburn J, Morgan MJ, Thorburn A. 2012. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy. 8:200–212.
   PubMed Web of Science ®Google Scholar
• Maynadier M, Vezenkov LL, Amblard M, Martin V, Gandreuil C, Vaillant O, Gary-Bobo M, Basile I, Hernandez JF, Garcia M, Martinez J. 2013. Dipeptide mimic oligomer transporter mediates intracellular delivery of cathepsin D inhibitors: a potential target for cancer therapy. J Control Release. 171:251–257.
   PubMed Web of Science ®Google Scholar
• McAfee Q, Zhang Z, Samanta A, Levi SM, Ma XH, Piao S, Lynch JP, Uehara T, Sepulveda AR, Davis LE, et al. 2012. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc Natl Acad Sci USA. 109:8253–8258.
   PubMed Web of Science ®Google Scholar
• Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, Montefusco S, Scotto-Rosato A, Prezioso C, Forrester A, et al. 2015. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol. 17:288–299.
   PubMed Web of Science ®Google Scholar
• Mehto S, Jena KK, Nath P, Chauhan S, Kolapalli SP, Das SK, Sahoo PK, Jain A, Taylor GA, Chauhan S. 2019. The Crohn's disease risk factor IRGM limits NLRP3 inflammasome activation by impeding Its assembly and by mediating Its selective autophagy. Mol Cell. 73:429–445. e427.
   PubMed Web of Science ®Google Scholar
• Meng D, Li Z, Wang G, Ling L, Wu Y, Zhang C. 2018. Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells. Biomed Pharmacother. 108:1617–1627.
   PubMed Web of Science ®Google Scholar
• Menikdiwela KR, Ramalingam L, Rasha F, Wang S, Dufour JM, Kalupahana NS, Sunahara KKS, Martins JO, Moustaid-Moussa N. 2020. Autophagy in metabolic syndrome: breaking the wheel by targeting the renin-angiotensin system. Cell Death Dis. 11:87.
   PubMed Web of Science ®Google Scholar
• Meo-Evoli N, Almacellas E, Massucci FA, Gentilella A, Ambrosio S, Kozma SC, Thomas G, Tauler A. 2015. V-ATPase: a master effector of E2F1-mediated lysosomal trafficking, mTORC1 activation and autophagy. Oncotarget. 6:28057–28070.
   PubMedGoogle Scholar
• Merk H, Messer P, Ardelt MA, Lamb DC, Zahler S, Muller R, Vollmar AM, Pachmayr J. 2017. Inhibition of the V-ATPase by archazolid A: A New strategy to inhibit EMT. Mol Cancer Ther. 16:2329–2339.
   PubMed Web of Science ®Google Scholar
• Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, et al. 2011. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science. 334:1573–1577.
   PubMed Web of Science ®Google Scholar
• Min L, Choy E, Pollock RE, Tu C, Hornicek F, Duan Z. 2017. Autophagy as a potential target for sarcoma treatment. Biochim Biophys Acta Rev Cancer. 1868:40–50.
   PubMed Web of Science ®Google Scholar
• Mindell JA. 2012. Lysosomal acidification mechanisms. Annu Rev Physiol. 74:69–86.
   PubMed Web of Science ®Google Scholar
• Mitrovic A, Kos J. 2019. Nitroxoline: repurposing its antimicrobial to antitumor application. Acta Biochim Pol. 66:521–531.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. 2011. Autophagy: renovation of cells and tissues. Cell. 147:728–741.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T, Ohsumi Y. 2011. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol. 27:107–132.
   PubMed Web of Science ®Google Scholar
• Mizutani Y, Maeda T, Murate K, Ito S, Watanabe H, Mutoh T. 2021. Clioquinol kills astrocyte-derived KT-5 cells by the impairment of the autophagy-lysosome pathway. Arch Toxicol. 95:631–640.
   PubMed Web of Science ®Google Scholar
• Mjahed H, Girodon F, Fontenay M, Garrido C. 2012. Heat shock proteins in hematopoietic malignancies. Exp Cell Res. 318:1946–1958.
   PubMed Web of Science ®Google Scholar
• Mollereau B, Walter L. 2019. Is WDR45 the missing link for ER stress-induced autophagy in beta-propeller associated neurodegeneration? Autophagy. 15:2163–2164.
   PubMed Web of Science ®Google Scholar
• Morel E, Mehrpour M, Botti J, Dupont N, Hamai A, Nascimbeni AC, Codogno P. 2017. Autophagy: A druggable process. Annu Rev Pharmacol Toxicol. 57:375–398.
   PubMed Web of Science ®Google Scholar
• Moriya S, Che XF, Komatsu S, Abe A, Kawaguchi T, Gotoh A, Inazu M, Tomoda A, Miyazawa K. 2013. Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells. Int J Oncol. 42:1541–1550.
   PubMed Web of Science ®Google Scholar
• Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC, Kroemer G. 2009. Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta. 1793:1524–1532.
   PubMed Web of Science ®Google Scholar
• Muzykewicz DA, Sharma A, Muse V, Numis AL, Rajagopal J, Thiele EA. 2009. TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex. J Med Genet. 46:465–468.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Kikukawa Y, Takeya M, Mitsuya H, Hata H. 2010. Clarithromycin attenuates autophagy in myeloma cells. Int J Oncol. 37:815–820.
   PubMed Web of Science ®Google Scholar
• Noda NN, Inagaki F. 2015. Mechanisms of autophagy. Annu Rev Biophys. 44:101–122.
   PubMed Web of Science ®Google Scholar
• Nordstrom LU, Sironi J, Aranda E, Maisonet J, Perez-Soler R, Wu P, Schwartz EL. 2015. Discovery of autophagy inhibitors with antiproliferative activity in lung and pancreatic cancer cells. ACS Med Chem Lett. 6:134–139.
   PubMed Web of Science ®Google Scholar
• Nosengo N. 2016. Can you teach old drugs new tricks? Nature. 534:314–316.
   PubMed Web of Science ®Google Scholar
• Nowak KL, Edelstein CL. 2020. Apoptosis and autophagy in polycystic kidney disease (PKD). Cell Signal. 68:109518.
   PubMed Web of Science ®Google Scholar
• Nwadike C, Williamson LE, Gallagher LE, Guan JL, Chan EYW. 2018. AMPK inhibits ULK1-dependent autophagosome formation and lysosomal acidification via distinct mechanisms. Mol Cell Biol. 38(10):e00023-18.
   Web of Science ®Google Scholar
• Oot RA, Couoh-Cardel S, Sharma S, Stam NJ, Wilkens S. 2017. Breaking up and making up: The secret life of the vacuolar H(+) -ATPase. Protein Sci. 26:896–909.
   PubMed Web of Science ®Google Scholar
• Oz-Levi D, Ben-Zeev B, Ruzzo EK, Hitomi Y, Gelman A, Pelak K, Anikster Y, Reznik-Wolf H, Bar-Joseph I, Olender T, et al. 2012. Mutation in TECPR2 reveals a role for autophagy in hereditary spastic paraparesis. Am J Hum Genet. 91:1065–1072.
   PubMed Web of Science ®Google Scholar
• Palmieri M, Impey S, Kang H, di Ronza A, Pelz C, Sardiello M, Ballabio A. 2011. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet. 20:3852–3866.
   PubMed Web of Science ®Google Scholar
• Pamarthy S, Kulshrestha A, Katara GK, Beaman KD. 2018. The curious case of vacuolar ATPase: regulation of signaling pathways. Mol Cancer. 17:41.
   PubMed Web of Science ®Google Scholar
• Pammolli F, Magazzini L, Riccaboni M. 2011. The productivity crisis in pharmaceutical R&D. Nat Rev Drug Discov. 10:428–438.
   PubMed Web of Science ®Google Scholar
• Pan B, Chen D, Huang J, Wang R, Feng B, Song H, Chen L. 2014. HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma. Mol Cancer. 13:165.
   PubMed Web of Science ®Google Scholar
• Pan H, Cai N, Li M, Liu GH, Izpisua Belmonte JC. 2013. Autophagic control of cell ‘stemness’. EMBO Mol Med. 5:327–331.
   PubMed Web of Science ®Google Scholar
• Papadopoulos C, Kravic B, Meyer H. 2020. Repair or lysophagy: dealing with damaged lysosomes. J Mol Biol. 432:231–239.
   PubMed Web of Science ®Google Scholar
• Papadopoulos C, Meyer H. 2017. Detection and clearance of damaged lysosomes by the endo-lysosomal damage response and lysophagy. Curr Biol. 27:R1330–R1341.
   PubMed Web of Science ®Google Scholar
• Parenti G, Andria G, Ballabio A. 2015. Lysosomal storage diseases: from pathophysiology to therapy. Annu Rev Med. 66:471–486.
   PubMed Web of Science ®Google Scholar
• Park JM, Tougeron D, Huang S, Okamoto K, Sinicrope FA, Ulasov I. 2014. Beclin 1 and UVRAG confer protection from radiation-induced DNA damage and maintain centrosome stability in colorectal cancer cells. PLoS One. 9:e100819.
   PubMed Web of Science ®Google Scholar
• Pascolo S. 2016. Time to use a dose of chloroquine as an adjuvant to anti-cancer chemotherapies. Eur J Pharmacol. 771:139–144.
   PubMed Web of Science ®Google Scholar
• Pasquier B. 2015. SAR405, a PIK3C3/Vps34 inhibitor that prevents autophagy and synergizes with MTOR inhibition in tumor cells. Autophagy. 11:725–726.
   PubMed Web of Science ®Google Scholar
• Paz I, Sachse M, Dupont N, Mounier J, Cederfur C, Enninga J, Leffler H, Poirier F, Prevost MC, Lafont F, Sansonetti P. 2010. Galectin-3, a marker for vacuole lysis by invasive pathogens. Cell Microbiol. 12:530–544.
   PubMed Web of Science ®Google Scholar
• Pecoraro A, Pagano M, Russo G, Russo A. 2020. Role of autophagy in cancer cell response to nucleolar and endoplasmic reticulum stress. Int J Mol Sci. 21(19):7334.
   Web of Science ®Google Scholar
• Pellegrini P, Strambi A, Zipoli C, Hagg-Olofsson M, Buoncervello M, Linder S, De Milito A. 2014. Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine: implications for cancer therapies. Autophagy. 10:562–571.
   PubMed Web of Science ®Google Scholar
• Penke B, Bogar F, Crul T, Santha M, Toth ME, Vigh L. 2018. Heat shock proteins and autophagy pathways in neuroprotection: from molecular bases to pharmacological interventions. Int J Mol Sci. 19:325.
   PubMed Web of Science ®Google Scholar
• Perera RM, Zoncu R. 2016. The lysosome as a regulatory Hub. Annu Rev Cell Dev Biol. 32:223–253.
   PubMed Web of Science ®Google Scholar
• Perez-Mancera PA, Young AR, Narita M. 2014. Inside and out: the activities of senescence in cancer. Nat Rev Cancer. 14:547–558.
   PubMed Web of Science ®Google Scholar
• Petersen NH, Olsen OD, Groth-Pedersen L, Ellegaard AM, Bilgin M, Redmer S, Ostenfeld MS, Ulanet D, Dovmark TH, Lonborg A, et al. 2013. Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase. Cancer Cell. 24:379–393.
   PubMed Web of Science ®Google Scholar
• Piao S, Amaravadi RK. 2016. Targeting the lysosome in cancer. Ann N Y Acad Sci. 1371:45–54.
   PubMed Web of Science ®Google Scholar
• Pickrell AM, Youle RJ. 2015. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron. 85:257–273.
   PubMed Web of Science ®Google Scholar
• Platt FM, d'Azzo A, Davidson BL, Neufeld EF, Tifft CJ. 2018. Lysosomal storage diseases. Nat Rev Dis Primers. 4:27.
   PubMed Web of Science ®Google Scholar
• Pogorzelska A, Zolnowska B, Bartoszewski R. 2018. Cysteine cathepsins as a prospective target for anticancer therapies-current progress and prospects. Biochimie. 151:85–106.
   PubMed Web of Science ®Google Scholar
• Poulogiannis G, McIntyre RE, Dimitriadi M, Apps JR, Wilson CH, Ichimura K, Luo F, Cantley LC, Wyllie AH, Adams DJ, Arends MJ. 2010. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc Natl Acad Sci USA. 107:15145–15150.
   PubMed Web of Science ®Google Scholar
• Pu J, Guardia CM, Keren-Kaplan T, Bonifacino JS. 2016. Mechanisms and functions of lysosome positioning. J Cell Sci. 129:4329–4339.
   PubMed Web of Science ®Google Scholar
• Qiu W, Su M, Xie F, Ai J, Ren Y, Zhang J, Guan R, He W, Gong Y, Guo Y. 2014. Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells. Cell Death Dis. 5:e1123.
   PubMed Web of Science ®Google Scholar
• Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al. 2003. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 112:1809–1820.
   PubMed Web of Science ®Google Scholar
• Qureshi-Baig K, Kuhn D, Viry E, Pozdeev VI, Schmitz M, Rodriguez F, Ullmann P, Koncina E, Nurmik M, Frasquilho S, et al. 2020. Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway. Autophagy. 16:1436–1452.
   PubMed Web of Science ®Google Scholar
• Radulovic M, Schink KO, Wenzel EM, Nahse V, Bongiovanni A, Lafont F, Stenmark H. 2018. ESCRT-mediated lysosome repair precedes lysophagy and promotes cell survival. EMBO J. 37(21): e99753.
   Web of Science ®Google Scholar
• Ramessur KT, Greenwell P, Nash R, Dwek MV. 2010. Breast cancer invasion is mediated by beta-N-acetylglucosaminidase (beta-NAG) and associated with a dysregulation in the secretory pathway of cancer cells. Br J Biomed Sci. 67:189–196.
   PubMed Web of Science ®Google Scholar
• Rangwala R, Leone R, Chang YC, Fecher LA, Schuchter LM, Kramer A, Tan KS, Heitjan DF, Rodgers G, Gallagher M, et al. 2014. Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy. 10:1369–1379.
   PubMed Web of Science ®Google Scholar
• Rao S, Yang H, Penninger JM, Kroemer G. 2014. Autophagy in non-small cell lung carcinogenesis: A positive regulator of antitumor immunosurveillance. Autophagy. 10:529–531.
   PubMed Web of Science ®Google Scholar
• Rebecca VW, Nicastri MC, McLaughlin N, Fennelly C, McAfee Q, Ronghe A, Nofal M, Lim CY, Witze E, Chude CI, et al. 2017. A unified approach to targeting the lysosome's degradative and growth signaling roles. Cancer Discov. 7:1266–1283.
   PubMed Web of Science ®Google Scholar
• Renna M, Schaffner C, Brown K, Shang S, Tamayo MH, Hegyi K, Grimsey NJ, Cusens D, Coulter S, Cooper J, et al. 2011. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest. 121:3554–3563.
   PubMed Web of Science ®Google Scholar
• Renvoise B, Chang J, Singh R, Yonekawa S, FitzGibbon EJ, Mankodi A, Vanderver A, Schindler A, Toro C, Gahl WA, et al. 2014. Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11. Ann Clin Transl Neurol. 1:379–389.
   PubMed Web of Science ®Google Scholar
• Rofstad EK, Mathiesen B, Kindem K, Galappathi K. 2006. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 66:6699–6707.
   PubMed Web of Science ®Google Scholar
• Rojas-Puentes LL, Gonzalez-Pinedo M, Crismatt A, Ortega-Gomez A, Gamboa-Vignolle C, Nunez-Gomez R, Dorantes-Gallareta Y, Arce-Salinas C, Arrieta O. 2013. Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases. Radiat Oncol. 8:209.
   PubMed Web of Science ®Google Scholar
• Ronan B, Flamand O, Vescovi L, Dureuil C, Durand L, Fassy F, Bachelot MF, Lamberton A, Mathieu M, Bertrand T, et al. 2014. A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. Nat Chem Biol. 10:1013–1019.
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Codogno P, Levine B. 2012. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov. 11:709–730.
   PubMed Web of Science ®Google Scholar
• Rudzinska M, Parodi A, Soond SM, Vinarov AZ, Korolev DO, Morozov AO, Daglioglu C, Tutar Y, Zamyatnin AA, Jr. 2019. The role of cysteine cathepsins in cancer progression and drug resistance. Int J Mol Sci. 20(14): 3602.
   Web of Science ®Google Scholar
• Rybstein MD, Bravo-San Pedro JM, Kroemer G, Galluzzi L. 2018. The autophagic network and cancer. Nat Cell Biol. 20:243–251.
   PubMed Web of Science ®Google Scholar
• Sabatini DM. 2017. Twenty-five years of mTOR: uncovering the link from nutrients to growth. Proc Natl Acad Sci USA. 114:11818–11825.
   PubMed Web of Science ®Google Scholar
• Saftig P, Klumperman J. 2009. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol. 10:623–635.
   PubMed Web of Science ®Google Scholar
• Saftig P, Sandhoff K. 2013. Cancer: killing from the inside. Nature. 502:312–313.
   PubMed Web of Science ®Google Scholar
• Sander P, Mostafa H, Soboh A, Schneider JM, Pala A, Baron AK, Moepps B, Wirtz CR, Georgieff M, Schneider M. 2017. Vacquinol-1 inducible cell death in glioblastoma multiforme is counter regulated by TRPM7 activity induced by exogenous ATP. Oncotarget. 8:35124–35137.
   PubMedGoogle Scholar
• Savic R, Schuchman EH. 2013. Use of acid sphingomyelinase for cancer therapy. Adv Cancer Res. 117:91–115.
   PubMed Web of Science ®Google Scholar
• Scannell JW, Blanckley A, Boldon H, Warrington B. 2012. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 11:191–200.
   PubMed Web of Science ®Google Scholar
• Schurigt U, Schad C, Glowa C, Baum U, Thomale K, Schnitzer JK, Schultheis M, Schaschke N, Schirmeister T, Moll H. 2010. Aziridine-2,3-dicarboxylate-based cysteine cathepsin inhibitors induce cell death in Leishmania major associated with accumulation of debris in autophagy-related lysosome-like vacuoles. Antimicrob Agents Chemother. 54:5028–5041.
   PubMed Web of Science ®Google Scholar
• Seitz C, Hugle M, Cristofanon S, Tchoghandjian A, Fulda S. 2013. The dual PI3K/mTOR inhibitor NVP-BEZ235 and chloroquine synergize to trigger apoptosis via mitochondrial-lysosomal cross-talk. Int J Cancer. 132:2682–2693.
   PubMed Web of Science ®Google Scholar
• Selvakumaran M, Amaravadi RK, Vasilevskaya IA, O'Dwyer PJ. 2013. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy. Clin Cancer Res. 19:2995–3007.
   PubMed Web of Science ®Google Scholar
• Sennoune SR, Bakunts K, Martinez GM, Chua-Tuan JL, Kebir Y, Attaya MN, Martinez-Zaguilan R. 2004. Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol. 286:C1443–C1452.
   PubMed Web of Science ®Google Scholar
• Serrano-Puebla A, Boya P. 2016. Lysosomal membrane permeabilization in cell death: new evidence and implications for health and disease. Ann N Y Acad Sci. 1371:30–44.
   PubMed Web of Science ®Google Scholar
• Settembre C, De Cegli R, Mansueto G, Saha PK, Vetrini F, Visvikis O, Huynh T, Carissimo A, Palmer D, Klisch TJ, et al. 2013. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat Cell Biol. 15:647–658.
   PubMed Web of Science ®Google Scholar
• Settembre C, Fraldi A, Medina DL, Ballabio A. 2013. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol. 14:283–296.
   PubMed Web of Science ®Google Scholar
• Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard MC, et al. 2012. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31:1095–1108.
   PubMed Web of Science ®Google Scholar
• Shao BZ, Yao Y, Zhai JS, Zhu JH, Li JP, Wu K. 2021. The role of autophagy in inflammatory bowel disease. Front Physiol. 12:621132.
   PubMed Web of Science ®Google Scholar
• Shao S, Li S, Qin Y, Wang X, Yang Y, Bai H, Zhou L, Zhao C, Wang C. 2014. Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia. Int J Oncol. 44:1661–1668.
   PubMed Web of Science ®Google Scholar
• Sharif T, Martell E, Dai C, Kennedy BE, Murphy P, Clements DR, Kim Y, Lee PW, Gujar SA. 2017. Autophagic homeostasis is required for the pluripotency of cancer stem cells. Autophagy. 13:264–284.
   PubMed Web of Science ®Google Scholar
• Sharma N, Thomas S, Golden EB, Hofman FM, Chen TC, Petasis NA, Schonthal AH, Louie SG. 2012. Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. Cancer Lett. 326:143–154.
   PubMed Web of Science ®Google Scholar
• Sheng JQ, Wang MR, Fang D, Liu L, Huang WJ, Tian DA, He XX, Li PY. 2021. LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma. Biomed Pharmacother. 133:111023.
   PubMed Web of Science ®Google Scholar
• Simmen T, Tagaya M. 2017. Organelle communication at membrane contact sites (MCS): from curiosity to center stage in cell biology and biomedical research. Adv Exp Med Biol. 997:1–12.
   PubMed Web of Science ®Google Scholar
• Singh SS, Vats S, Chia AY, Tan TZ, Deng S, Ong MS, Arfuso F, Yap CT, Goh BC, Sethi G, et al. 2018. Dual role of autophagy in hallmarks of cancer. Oncogene. 37:1142–1158.
   PubMed Web of Science ®Google Scholar
• Sironi J, Aranda E, Nordstrom LU, Schwartz EL. 2019. Lysosome membrane permeabilization and disruption of the molecular target of rapamycin (mTOR)-lysosome interaction Are associated with the inhibition of lung cancer cell proliferation by a chloroquinoline analog. Mol Pharmacol. 95:127–138.
   PubMed Web of Science ®Google Scholar
• Skowyra ML, Schlesinger PH, Naismith TV, Hanson PI. 2018. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science. 360(6384): eaar5078.
   Web of Science ®Google Scholar
• Sosa MS, Bragado P, Aguirre-Ghiso JA. 2014. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 14:611–622.
   PubMed Web of Science ®Google Scholar
• Stock C, Pedersen SF. 2017. Roles of pH and the Na(+)/H(+) exchanger NHE1 in cancer: from cell biology and animal models to an emerging translational perspective? Semin Cancer Biol. 43:5–16.
   PubMed Web of Science ®Google Scholar
• Stoka V, Turk V, Turk B. 2016. Lysosomal cathepsins and their regulation in aging and neurodegeneration. Ageing Res Rev. 32:22–37.
   PubMed Web of Science ®Google Scholar
• Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, Han W, Lou F, Yang J, Zhang Q, et al. 2013. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 4:e838.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu JH, Jin L, Lin SM, Yang Y, Sui YX, Shi H. 2010. Over-expression of the Beclin1 gene upregulates chemosensitivity to anti-cancer drugs by enhancing therapy-induced apoptosis in cervix squamous carcinoma CaSki cells. Cancer Lett. 294:204–210.
   PubMed Web of Science ®Google Scholar
• Taherian E, Rao A, Malemud CJ, Askari AD. 2013. The biological and clinical activity of anti-malarial drugs in autoimmune disorders. Curr Rheumatol Rev. 9:45–62.
   PubMedGoogle Scholar
• Takamura A, Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S, Eishi Y, Hino O, Tanaka K, Mizushima N. 2011. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 25:795–800.
   PubMed Web of Science ®Google Scholar
• Tang Y, Wang XW, Liu ZH, Sun YM, Tang YX, Zhou DH. 2017. Chaperone-mediated autophagy substrate proteins in cancer. Oncotarget. 8:51970–51985.
   PubMedGoogle Scholar
• Taylor S, Spugnini EP, Assaraf YG, Azzarito T, Rauch C, Fais S. 2015. Microenvironment acidity as a major determinant of tumor chemoresistance: proton pump inhibitors (PPIs) as a novel therapeutic approach. Drug Resist Updat. 23:69–78.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. 2009. Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890.
   PubMed Web of Science ®Google Scholar
• Thurston TL, Wandel MP, von Muhlinen N, Foeglein A, Randow F. 2012. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature. 482:414–418.
   PubMed Web of Science ®Google Scholar
• Torgersen ML, Engedal N, Boe SO, Hokland P, Simonsen A. 2013. Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells. Blood. 122:2467–2476.
   PubMed Web of Science ®Google Scholar
• Torrente E, Parodi C, Ercolani L, De Mei C, Ferrari A, Scarpelli R, Grimaldi B. 2015. Synthesis and in vitro anticancer activity of the first class of dual inhibitors of REV-ERBbeta and autophagy. J Med Chem. 58:5900–5915.
   PubMed Web of Science ®Google Scholar
• Towers CG, Thorburn A. 2017. Targeting the lysosome for cancer therapy. Cancer Discov. 7:1218–1220.
   PubMed Web of Science ®Google Scholar
• Towers CG, Thorburn A. 2019. Circumventing autophagy inhibition. Cell Cycle. 18:3421–3431.
   PubMed Web of Science ®Google Scholar
• Towers CG, Wodetzki D, Thorburn A. 2020. Autophagy and cancer: modulation of cell death pathways and cancer cell adaptations. J Cell Biol. 219(1): e201909033.
   Web of Science ®Google Scholar
• Tran M, Reddy PH. 2020. Defective autophagy and mitophagy in aging and Alzheimer's disease. Front Neurosci. 14:612757.
   PubMed Web of Science ®Google Scholar
• Trivedi PC, Bartlett JJ, Pulinilkunnil T. 2020. Lysosomal biology and function: modern view of cellular debris Bin. Cells. 9:1131.
   PubMed Web of Science ®Google Scholar
• Turanli B, Grotli M, Boren J, Nielsen J, Uhlen M, Arga KY, Mardinoglu A. 2018. Drug repositioning for effective prostate cancer treatment. Front Physiol. 9:500.
   PubMed Web of Science ®Google Scholar
• Tzivion G, Dobson M, Ramakrishnan G. 2011. Foxo transcription factors; regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta. 1813:1938–1945.
   PubMed Web of Science ®Google Scholar
• Urquhart L. 2018. Market watch: Top drugs and companies by sales in 2017. Nat Rev Drug Discov. 17:232.
   PubMed Web of Science ®Google Scholar
• Usategui-Martin R, Gestoso-Uzal N, Calero-Paniagua I, De Pereda JM, Del Pino-Montes J, Gonzalez-Sarmiento R. 2020. A mutation in p62 protein (p. R321C), associated to Paget's disease of bone, causes a blockade of autophagy and an activation of NF-kB pathway. Bone. 133:115265.
   PubMed Web of Science ®Google Scholar
• Vanharanta S, Massague J. 2013. Origins of metastatic traits. Cancer Cell. 24:410–421.
   PubMed Web of Science ®Google Scholar
• Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, et al. 2010. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet. 42:77–82.
   PubMed Web of Science ®Google Scholar
• Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:229–240.
   PubMed Web of Science ®Google Scholar
• Verbaanderd C, Maes H, Schaaf MB, Sukhatme VP, Pantziarka P, Sukhatme V, Agostinis P, Bouche G. 2017. Repurposing drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents. Ecancermedicalscience. 11:781.
   PubMed Web of Science ®Google Scholar
• Wang P, Long M, Zhang S, Cheng Z, Zhao X, He F, Liu H, Ming L. 2017. Hypoxia inducible factor-1alpha regulates autophagy via the p27-E2F1 signaling pathway. Mol Med Rep. 16:2107–2112.
   PubMed Web of Science ®Google Scholar
• Wang T, Goodall ML, Gonzales P, Sepulveda M, Martin KR, Gately S, MacKeigan JP. 2015. Synthesis of improved lysomotropic autophagy inhibitors. J Med Chem. 58:3025–3035.
   PubMed Web of Science ®Google Scholar
• Wang X, Shen C, Liu Z, Peng F, Chen X, Yang G, Zhang D, Yin Z, Ma J, Zheng Z, et al. 2018. Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma. Cell Death Dis. 9:1032.
   PubMed Web of Science ®Google Scholar
• Wang XJ, Yang YS, Shen K, Wang J, Han F, Wu GF, Li Y, Bai XZ, Luo L, Hu DH. 2020. [Effects and mechanism of pyrroloquinoline quinine on mitochondrial function and cell survival of rat bone marrow mesenchymal stem cells under oxidative stress]. Zhonghua Shao Shang Za Zhi. 36:378–387.
   PubMedGoogle Scholar
• Wang Y, Zhang N, Zhang L, Li R, Fu W, Ma K, Li X, Wang L, Wang J, Zhang H, et al. 2016. Autophagy regulates chromatin ubiquitination in DNA damage response through elimination of SQSTM1/p62. Mol Cell. 63:34–48.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang J, Wang Y, Xing R, Yi C, Zhu H, Chen X, Guo J, Guo W, Li W, et al. 2013. Matrine, a novel autophagy inhibitor, blocks trafficking and the proteolytic activation of lysosomal proteases. Carcinogenesis. 34:128–138.
   PubMed Web of Science ®Google Scholar
• Waring MJ, Arrowsmith J, Leach AR, Leeson PD, Mandrell S, Owen RM, Pairaudeau G, Pennie WD, Pickett SD, Wang J, et al. 2015. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat Rev Drug Discov. 14:475–486.
   PubMed Web of Science ®Google Scholar
• Wei W, Ren J, Yin W, Ding H, Lu Q, Tan L, Deng S, Liu J, Yang Q, Wang J, et al. 2020. Inhibition of ctsk modulates periodontitis with arthritis via downregulation of TLR9 and autophagy. Cell Prolif. 53:e12722.
   PubMed Web of Science ®Google Scholar
• Weihl CC, Iyadurai S, Baloh RH, Pittman SK, Schmidt RE, Lopate G, Pestronk A, Harms MB. 2015. Autophagic vacuolar pathology in desminopathies. Neuromuscul Disord. 25:199–206.
   PubMed Web of Science ®Google Scholar
• White E. 2015. The role for autophagy in cancer. J Clin Invest. 125:42–46.
   PubMed Web of Science ®Google Scholar
• White KA, Grillo-Hill BK, Barber DL. 2017. Cancer cell behaviors mediated by dysregulated pH dynamics at a glance. J Cell Sci. 130:663–669.
   PubMed Web of Science ®Google Scholar
• Wilkinson RD, Williams R, Scott CJ, Burden RE. 2015. Cathepsin S: therapeutic, diagnostic, and prognostic potential. Biol Chem. 396:867–882.
   PubMed Web of Science ®Google Scholar
• Wong VKW, Zeng W, Chen J, Yao XJ, Leung ELH, Wang QQ, Chiu P, Ko BCB, Law BYK. 2017. Tetrandrine, an activator of autophagy, induces autophagic cell death via PKC-alpha inhibition and mTOR-dependent mechanisms. Front Pharmacol. 8:351.
   PubMed Web of Science ®Google Scholar
• Workman P. 2020. Reflections and outlook on targeting HSP90, HSP70 and HSF1 in cancer: A personal perspective. Adv Exp Med Biol. 1243:163–179.
   PubMed Web of Science ®Google Scholar
• Xie H, Li C, Zhang M, Zhong N, Chen L. 2017. Association between IRGM polymorphisms and tuberculosis risk: A meta-analysis. Medicine (Baltimore). 96:e8189.
   PubMed Web of Science ®Google Scholar
• Xiong D, Wang Y, Kupert E, Simpson C, Pinney SM, Gaba CR, Mandal D, Schwartz AG, Yang P, de Andrade M, et al. 2015. A recurrent mutation in PARK2 is associated with familial lung cancer. Am J Hum Genet. 96:301–308.
   PubMed Web of Science ®Google Scholar
• Xu N, Lin W, Sun J, Sadahira T, Xu A, Watanabe M, Guo K, Araki M, Li G, Liu C, et al. 2020. Nitroxoline inhibits bladder cancer progression by reversing EMT process and enhancing anti-tumor immunity. J Cancer. 11:6633–6641.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Ma X. 2009. Role of Nod2 in the development of Crohn's disease. Microbes Infect. 11:912–918.
   PubMed Web of Science ®Google Scholar
• Yan Y, Zhou K, Wang L, Wang F, Chen X, Fan Q. 2017. Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer. Onco Targets Ther. 10:1947–1954.
   PubMed Web of Science ®Google Scholar
• Yang B, Xu QY, Guo CY, Huang JW, Wang SM, Li YM, Tu Y, He L, Bi ZG, Ji C, Cheng B. 2017. MHY1485 ameliorates UV-induced skin cell damages via activating mTOR-Nrf2 signaling. Oncotarget. 8:12775–12783.
   PubMedGoogle Scholar
• Yang PW, Hsieh MS, Chang YH, Huang PM, Lee JM. 2017. Genetic polymorphisms of ATG5 predict survival and recurrence in patients with early-stage esophageal squamous cell carcinoma. Oncotarget. 8:91494–91504.
   PubMedGoogle Scholar
• Yao D, GangYi Y, QiNan W. 2021. Autophagic dysfunction of beta cell dysfunction in type 2 diabetes, a double-edged sword. Genes Dis. 8:438–447.
   PubMed Web of Science ®Google Scholar
• Yao RQ, Ren C, Xia ZF, Yao YM. 2021. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. Autophagy. 17:385–401.
   PubMed Web of Science ®Google Scholar
• Yazdani HO, Huang H, Tsung A. 2019. Autophagy: dual response in the development of hepatocellular carcinoma. Cells. 8(2): 91.
   Web of Science ®Google Scholar
• Yella JK, Yaddanapudi S, Wang Y, Jegga AG. 2018. Changing Trends in computational drug repositioning. Pharmaceuticals (Basel). 11:57.
   PubMedGoogle Scholar
• Yoshida Y, Yasuda S, Fujita T, Hamasaki M, Murakami A, Kawawaki J, Iwai K, Saeki Y, Yoshimori T, Matsuda N, Tanaka K. 2017. Ubiquitination of exposed glycoproteins by SCF(FBXO27) directs damaged lysosomes for autophagy. Proc Natl Acad Sci USA. 114:8574–8579.
   PubMed Web of Science ®Google Scholar
• You H, Jin J, Shu H, Yu B, De Milito A, Lozupone F, Deng Y, Tang N, Yao G, Fais S, et al. 2009. Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells. Cancer Lett. 280:110–119.
   PubMed Web of Science ®Google Scholar
• Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JF, Tavare S, Arakawa S, Shimizu S, Watt FM, Narita M. 2009. Autophagy mediates the mitotic senescence transition. Genes Dev. 23:798–803.
   PubMed Web of Science ®Google Scholar
• Yu L, Chen Y, Tooze SA. 2018. Autophagy pathway: cellular and molecular mechanisms. Autophagy. 14:207–215.
   PubMed Web of Science ®Google Scholar
• Yun CW, Lee SH. 2018. The roles of autophagy in cancer. Int J Mol Sci. 19(11): 3466.
   Google Scholar
• Zada S, Hwang JS, Ahmed M, Lai TH, Pham TM, Elashkar O, Kim DR. 2021. Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy. Biochim Biophys Acta Rev Cancer. 1876:188565.
   PubMed Web of Science ®Google Scholar
• Zeh HJ, Bahary N, Boone BA, Singhi AD, Miller-Ocuin JL, Normolle DP, Zureikat AH, Hogg ME, Bartlett DL, Lee KK, et al. 2020. A randomized phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine/Nab-Paclitaxel in pancreatic cancer patients. Clin Cancer Res. 26:3126–3134.
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen L, Sun X, Yang Q, Wan L, Guo C. 2020. Matrine: A promising natural product With various pharmacological activities. Front Pharmacol. 11:588.
   PubMed Web of Science ®Google Scholar
• Zhang MY, Wang LY, Zhao S, Guo XC, Xu YQ, Zheng ZH, Lu H, Zheng HC. 2019. Effects of beclin 1 overexpression on aggressive phenotypes of colon cancer cells. Oncol Lett. 17:2441–2450.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang S, Wang Q, Yang Z, Pan Z, Li L. 2014. Overexpression of cysteine cathepsin L is a marker of invasion and metastasis in ovarian cancer. Oncol Rep. 31:1334–1342.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liao Z, Zhang LJ, Xiao HT. 2015. The utility of chloroquine in cancer therapy. Curr Med Res Opin. 31:1009–1013.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sowers JR, Ren J. 2018. Targeting autophagy in obesity: from pathophysiology to management. Nat Rev Endocrinol. 14:356–376.
   PubMed Web of Science ®Google Scholar
• Zhao X, Ayer RE, Davis SL, Ames SJ, Florence B, Torchinsky C, Liou JS, Shen L, Spanjaard RA. 2005. Apoptosis factor EI24/PIG8 is a novel endoplasmic reticulum-localized Bcl-2-binding protein which is associated with suppression of breast cancer invasiveness. Cancer Res. 65:2125–2129.
   PubMed Web of Science ®Google Scholar
• Zhao X, Fang Y, Yang Y, Qin Y, Wu P, Wang T, Lai H, Meng L, Wang D, Zheng Z, et al. 2015. Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells. Autophagy. 11:1849–1863.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Lu Y, Ma J, Zhu L. 2015. Synthesis and evaluation of cleistanthin A derivatives as potent vacuolar H(+) -ATPase inhibitors. Chem Biol Drug Des. 86:691–696.
   PubMed Web of Science ®Google Scholar
• Zhitomirsky B, Assaraf YG. 2016. Lysosomes as mediators of drug resistance in cancer. Drug Resist Updat. 24:23–33.
   PubMed Web of Science ®Google Scholar
• Zhou J, Li G, Zheng Y, Shen HM, Hu X, Ming QL, Huang C, Li P, Gao N. 2015. A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission. Autophagy. 11:1259–1279.
   PubMed Web of Science ®Google Scholar
• Zhou XJ, Lu XL, Lv JC, Yang HZ, Qin LX, Zhao MH, Su Y, Li ZG, Zhang H. 2011. Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population. Ann Rheum Dis. 70:1330–1337.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ma J, Zhang J, He L, Gong J, Long C. 2017. Pifithrin-mu is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70. Oncol Rep. 37:313–322.
   PubMed Web of Science ®Google Scholar
• Zhu L, Wang H, Wu Y, He Z, Qin Y, Shen Q. 2017. The autophagy level Is increased in the synovial tissues of patients with active rheumatoid arthritis and Is correlated with disease severity. Mediators Inflamm. 2017:7623145.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zhang Q, Gu M, Zhang K, Xia T, Zhang S, Chen W, Yin H, Yao H, Fan Y, et al. 2021. MIR106A-5p upregulation suppresses autophagy and accelerates malignant phenotype in nasopharyngeal carcinoma. Autophagy. 17:1667–1683.
   PubMed Web of Science ®Google Scholar
• Zhu SY, Yao RQ, Li YX, Zhao PY, Ren C, Du XH, Yao YM. 2020. Lysosomal quality control of cell fate: a novel therapeutic target for human diseases. Cell Death Dis. 11:817.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Kepp O, Galluzzi L, Kroemer G. 2012. Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol. 13:343–351.
   PubMed Web of Science ®Google Scholar